The new BMC2 Executive Board brings together internationally recognized experts and will support the consortium by elevating the data, people, and BMC2 mission for purposeful impact.
The board will provide insight, guidance, and influence on:
- Strategic Leadership
- Collaborative Engagement
- Policy Development and National Impact
- Innovation Advancement
- Communication
- Return On Investment
The inaugural meeting was held on November 7th, 2026, in Chicago, where BMC2 Coordinating Center leaders and directors introduced the board to many of BMC2's programs, including Vascular Surgery (Dr. Nick Osborne), Heart Failure (Dr. Jessica Golbus), PCI (Dr. Eric Cantey), and the BMC2 Coordinating Center (Mollie Bodin).
Board members include Dr. Rasha Al-Lamee, Dr. David J. Cohen, Dr. James Grant, Dr. Caitlin W. Hicks, and Dr. Sunil V. Rao. Dr. Hitinder Gurm serves as the board chair. You can learn more about the board members on bmc2.org.
This team strongly believes in BMC2’s vision to steadily impact Michigan’s and the United States’ number one health problem, cardiovascular disease, and brings broad diversity in background, interest, experience, and leadership.
"At the heart of BMC2's work is a commitment to share knowledge, learn from each other, and execute improvements focused on safety, quality, and appropriateness for cardiovascular patients in Michigan," explained BMC2 Program Director, Dr. Nick Osborne. "We are honored to partner with the Executive Board and expand our learning and reach as we welcome these new members of the BMC2 team."
Meetings will be held twice yearly: one virtual meeting and one in-person meeting, alongside a national meeting.